New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...

Russian attackers were behind the hack of the European Medicines Agency EMA in 2020. They had “unauthorized access to ...

The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.

Czechia proposes changes that will better define the role of patient organisations when informing patients about therapeutic procedures without violating advertising regulations.

Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...

EMA establishes regular procedure for scientific advice on certain high-risk medical devices: Amsterdam, The Netherlands Wednesday, February 12, 2025, 13:00 Hrs [IST] EMA, in clos ...

The USD/CAD pair encounters initial resistance at the nine-day EMA of 1.4362, followed by the 14-day EMA at 1.4373. A break ...

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The ...

CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEM ...

Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of ...

The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike. Following a turbulent period marked by Brexit and the ...